Roth CH Acquisition I Co. (ROCHU), announced the pricing of their $75 million SPAC IPO this evening and the units are expected to begin trading tomorrow, Tuesday, May 5th, under the symbol Nasdaq: ROCHU.
Roth CH Acquisition I Co. intends to focus on companies in a broad range of sectors including healthcare, wellness, consumer and technology. Additionally, Roth CH will be led by Byron Roth, as Chairman and Chief Executive Officer, and will be joined by Co-Presidents Rick Hartfiel and Aaron Gurewitz.
Total SPAC deal count for 2020 year-to-date is now 20 with $6.236 billion in gross proceeds raised. The offering is anticipated to close on Thursday, May 7, 2020.
Roth Capital Partners and Craig-Hallum Capital Group are acting as joint book-running managers of the offering. Loeb & Loeb LLP and Graubard Miller were Issuer’s Counsel and Underwriter’s Counsel, respectively. Marcum LLP acted as auditor.
Vendome Acquisition Corporation I (NASDAQ:VNMEU) announced the pricing of its $200 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “VNMEU”, Wednesday, July 2, 2025. The new SPAC plans to focus its search on target business in the consumer sector operating in North America, Southeast Asia, and Europe....
Origin Investment Corp. I (NASDAQ:ORIQU) announced the pricing of its $60 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ORIQU”, Wednesday, July 2, 2025. The new SPAC aims to mount a broad search for a target with a strong management and both revenue and earnings growth potential....
1RT Acquisition Corp. (NASDAQ:ONCHU) announced the pricing of its $150 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ONCHU”, Wednesday, July 2, 2025. The new SPAC plans to target company in the digital asset ecosystem involved in the creation, storage, exchange or management of such assets, whether...
D. Boral ARC Acquisition II Corp. (NASDAQ:ARBCU) has filed for a $250 million SPAC to give underwriter D. Boral a second in-house SPAC to pursue deals with. The new SPAC offers investors a 1/2 warrant and an initial 18-month time frame to complete a deal. D. Boral II’s sponsor may automatically extend this once by...
Ribbon (NASDAQ:RIBB) has entered into a definitive agreement to combine with Japanese biotech firm DRC Medicine at a pro forma equity value of $422 million. Tokyo-based DRC Medicine manufactures reusable anti-bacterial and anti-allergen wearables and aims to go deeper into the medical device and pharmaceutical space. Transaction Overview Ribbon is expected to provide $50.4 million...